Allspring Global Investments
TNGX icon

Allspring Global Investments’s Tango Therapeutics TNGX Stock Holding History

Allspring Global Investments’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Buy
+13,200
New +$326K ﹤0.01% 1525
2023
Q4 		– Sell
-8,157
Closed -$91.8K – 2724
2023
Q3 		$91.8K Sell
8,157
-6,315
-44% -$38.5K ﹤0.01% 2031
2023
Q2 		$48K Buy
+14,472
New +$52.1K ﹤0.01% 2298
2023
Q1 		– Sell
-28,730
Closed -$208K – 2937
2022
Q4 		$208K Sell
28,730
-42,253
-60% -$297K ﹤0.01% 1815
2022
Q3 		$256K Buy
+70,983
New +$303K ﹤0.01% 1749

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Allspring Global Investments's TNGX Position: Q2 2026 in Review

Allspring Global Investments opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 13,200 shares worth $379K. The stake represents ﹤0.01% of the portfolio and ranks #1525 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in TNGX as recently as Q3 2023.

Allspring Global Investments first reported a position in TNGX in Q3 2022 and has held it in 5 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Allspring Global Investments held 13,200 shares of Tango Therapeutics worth $379K as of Q2 2026.
  • Tango Therapeutics was a new Allspring Global Investments position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1525 holding.
  • Allspring Global Investments first reported a position in Tango Therapeutics in Q3 2022 and has held it in 5 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.